You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 20, 2024

Investigational Drug Information for Chronocort

✉ Email this page to a colleague

« Back to Dashboard

What is the drug development status for Chronocort?

Chronocort is an investigational drug.

There have been 11 clinical trials for Chronocort. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2021.

The most common disease conditions in clinical trials are Hyperplasia, Adrenogenital Syndrome, and Adrenal Hyperplasia, Congenital. The leading clinical trial sponsors are Diurnal Limited, Simbec Research, and National Institutes of Health (NIH).

There are five hundred and eighty-seven US patents protecting this investigational drug and zero international patents.

Recent Clinical Trials for Chronocort
Long-term Safety Study of Chronocort in the Treatment of Participants With Congenital Adrenal HyperplasiaDiurnal LimitedPhase 3
Chronocort Versus Plenadren Replacement Therapy in Adults With Adrenal InsufficiencyDiurnal LimitedPhase 2
Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal HyperplasiaDiurnal LimitedPhase 3

See all Chronocort clinical trials

Clinical Trial Summary for Chronocort

Top disease conditions for Chronocort
Top clinical trial sponsors for Chronocort

See all Chronocort clinical trials

US Patents for Chronocort

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Chronocort ⤷  Sign Up Methods and compositions for inhibition of Ras ARAXES PHARMA LLC (San Diego, CA) ⤷  Sign Up
Chronocort ⤷  Sign Up IBAT inhibitors for the treatment of liver diseases Albireo AB (Gothenburg, SE) ⤷  Sign Up
Chronocort ⤷  Sign Up Ammonia oxidizing bacteria for treatment of eczema AOBIOME LLC (Cambridge, MA) ⤷  Sign Up
Chronocort ⤷  Sign Up Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same STC.UNM (Albuquerque, NM) Sandia Corporation (Albuquerque, NM) ⤷  Sign Up
Chronocort ⤷  Sign Up Pyrrolidine amide compounds as histone demethylase inhibitors GENENTECH, INC. (South San Francisco, CA) CONSTELLATION PHARMACEUTICALS INC. (Cambridge, MA) ⤷  Sign Up
Chronocort ⤷  Sign Up Androgen receptor modulators and uses thereof Aragon Pharmaceuticals, Inc. (San Diego, CA) ⤷  Sign Up
Chronocort ⤷  Sign Up In situ hybridization method and buffer EXIQON A/S (Vedbaek, DK) ⤷  Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Chronocort

Drugname Country Document Number Estimated Expiration Related US Patent
Chronocort World Intellectual Property Organization (WIPO) WO2015087340 1989-12-31 ⤷  Sign Up
Chronocort European Patent Office EP3158977 2035-10-20 ⤷  Sign Up
Chronocort Australia AU2010206683 2029-01-23 ⤷  Sign Up
Chronocort Brazil BRPI1006942 2029-01-23 ⤷  Sign Up
Chronocort Canada CA2749217 2029-01-23 ⤷  Sign Up
Chronocort China CN102356075 2029-01-23 ⤷  Sign Up
Chronocort Cyprus CY1115187 2029-01-23 ⤷  Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.